Cargando…

CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario

CanAssist Breast (CAB) has thus far been validated on a retrospective cohort of 1123 patients who are mostly Indians. Distant metastasis–free survival (DMFS) of more than 95% was observed with significant separation (P < 0.0001) between low-risk and high-risk groups. In this study, we demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sankaran, Satish, Dikshit, Jyoti Bajpai, Prakash SV, Chandra, Mallikarjuna, SE, Somashekhar, SP, Patil, Shekhar, Kumar, Rajeev, Prasad, Krishna, Shet, Dinesh, Bakre, Manjiri M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119549/ https://www.ncbi.nlm.nih.gov/pubmed/33994724 http://dx.doi.org/10.1007/s13193-019-01014-4

Ejemplares similares

The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment
por: Eshwaraiah, Mallikarjuna Siraganahalli, et al.
Publicado: (2023)

The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin
por: Chandra Doval, Dinesh, et al.
Publicado: (2021)

A comparative analysis of recurrence risk predictions in ER+/HER2− early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast
por: Gunda, Aparna, et al.
Publicado: (2022)

Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX
por: Sengupta, Aditya K., et al.
Publicado: (2020)

Clinical validation of an immunohistochemistry‐based CanAssist‐Breast test for distant recurrence prediction in hormone receptor‐positive breast cancer patients
por: Bakre, Manjiri M., et al.
Publicado: (2019)

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort
por: Gunda, Aparna, et al.
Publicado: (2022)

Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients
por: Attuluri, Arun Kumar, et al.
Publicado: (2019)

Robust Guidelines for the Management of HR+ Her2− EBC: Crucial Value of CanAssist Breast
por: Vaid, Ashok, et al.
Publicado: (2022)

Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial
por: Zhang, Xi, et al.
Publicado: (2023)

Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
por: Govindan, Sindhu, et al.
Publicado: (2020)

To Give or Not to Give Adjuvant Chemotherapy in Breast Cancer? Can CanAssist Breast Assist?
por: Akhade, Amol, et al.
Publicado: (2022)

Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method
por: Parikh, Purvish, et al.
Publicado: (2023)

Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India
por: Parikh, Purvish M., et al.
Publicado: (2021)

Overview of Breast Cancer and Implications of Overtreatment of Early-Stage Breast Cancer: An Indian Perspective
por: Bhattacharyya, Gouri Shankar, et al.
Publicado: (2020)

Breast cancer: An overview of published Indian data
por: Rangarajan, Bharath, et al.
Publicado: (2016)

Long-term outcomes and prognostic factors in elderly patients with breast cancer: single-institutional experience
por: Wadasadawala, Tabassum, et al.
Publicado: (2023)

Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor–Positive Breast Cancer
por: Ramkumar, Charusheila, et al.
Publicado: (2018)

Optimizing Palbociclib Therapy Across the Age Spectrum: Hypothetical, Illustrative Case Scenarios in HR+, HER2–Metastatic Breast Cancer
por: Podsada, Kimberly, et al.
Publicado: (2020)

Activation of phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway and response to everolimus in endocrine receptor-positive metastatic breast cancer – A retrospective pilot analysis and viewpoint
por: Bajpai, Jyoti, et al.
Publicado: (2017)

Thoracic Tumors in Children and their Long-Term Outcomes: A Single-Center Experience
por: Patil, Neehar, et al.
Publicado: (2023)

Billiary obstruction in a metastatic tumor of the pancreas from breast cancer
por: Jyoti, Bajpai, et al.
Publicado: (2017)

Metachronous Venous Malformation Masquerading as an Obscure Gastrointestinal Bleed
por: Patil, Neehar, et al.
Publicado: (2022)

HR-MAS NMR Based Quantitative Metabolomics in Breast Cancer
por: Gogiashvili, Mikheil, et al.
Publicado: (2019)

Multi-Institutional Trends in Gynecological Robotic Surgery in India: A Real-World Scenario
por: Sinha, Rooma, et al.
Publicado: (2023)

Chronic disseminated intravascular coagulation presenting as renal mass
por: Somashekhar, Manjiri, et al.
Publicado: (2008)

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
por: Iwase, Toshiaki, et al.
Publicado: (2020)

Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer
por: Hussein, Shaimaa, et al.
Publicado: (2021)

Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer
por: Pegram, Mark, et al.
Publicado: (2023)

Taxane Combination Chemotherapy in Breast Cancer: Experience from a Tertiary Cancer Centre in India
por: Bajpai, Jyoti, et al.
Publicado: (2017)

Male breast cancer: is the scenario changing
por: Contractor, Kaiyumars B, et al.
Publicado: (2008)

Overview of the relevance of PI3K pathway in HR-positive breast cancer
por: Vasan, N, et al.
Publicado: (2019)

Sacituzumab Govitecan in HR-positive HER2-negative metastatic breast cancer
por: Nardin, Simone, et al.
Publicado: (2023)

The nuclear receptor Hr46/Hr3 is required in the blood brain barrier of mature males for courtship
por: Lama, Chamala, et al.
Publicado: (2022)

Oligometastatic breast cancer: A mini review
por: Rastogi, Sameer, et al.
Publicado: (2014)

Improving accuracy of breast cancer biomarker testing in India
por: Shet, Tanuja
Publicado: (2017)

Excellent response to erlotinib in breast carcinoma with rare EGFR mutation—a case report
por: Singh, Gunjesh Kumar, et al.
Publicado: (2020)

Pilomatrix Carcinoma Masquerading as Breast Carcinoma
por: Pai, Trupti, et al.
Publicado: (2017)

Current Breast Cancer Screening Scenario in Brazil
por: Tiezzi, Daniel Guimarães, et al.
Publicado: (2019)

An HR-MAS MR Metabolomics Study on Breast Tissues Obtained with Core Needle Biopsy
por: Li, MuLan, et al.
Publicado: (2011)

Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples
por: Haukaas, Tonje H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_352m3a4neq6tt938q6uh25cac1